Spatial proteomics represents a revolutionary frontier in molecular biology, enabling researchers to explore protein expression while preserving the critical spatial context of tissue architecture.

CHICAGO--(BUSINESS WIRE)--Nucleai, an AI-powered spatial biomarker and diagnostics company, today announced the launch of its deep learning model that automates the normalization of high-plex imaging ...

Deciphering protein spatial organization is essential for understanding complex disorders such as cancer. To better study cellular machinery important for health and disease, scientists can employ ...

Visualizes functional protein-protein interactions directly within fixed tissue at subcellular resolution Enables simultaneous detection of protein proximity, RNA, and proteins on the same tissue ...

Nucleai’s industry-leading solutions for AI-driven spatial analysis and quantitative biomarker scoring will be on display for biopharma companies exploring a biomarker-driven approach for their ADC ...

Multiomics is in vogue and several sequencing companies have taken notice. Rather than building capabilities for things like single-cell sequencing, spatial transcriptomics, and proteomics themselves, ...